Gerresheimer Makes Solid Start to the Financial Year 2024
Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries, continued its profitable growth trajectory in the first quarter of 2024 with organic revenue growth of 2.8% and an organic increase in adjusted EBITDA of 5.9%.
Gerresheimer Makes Solid Start to the Financial Year 2024 Read More »
